Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 7.09
-0.02 (-0.28%)
Apr 29, 2026, 3:04 PM CST
SHE:002550 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 677.5 | 491.05 | 439.95 | 576.23 | 409.26 | 617.81 | Upgrade
|
| Short-Term Investments | - | - | 192.9 | 64.95 | - | - | Upgrade
|
| Trading Asset Securities | 604.36 | 594.02 | 273.83 | 71.98 | 67.48 | 68.23 | Upgrade
|
| Cash & Short-Term Investments | 1,282 | 1,085 | 906.67 | 713.16 | 476.73 | 686.03 | Upgrade
|
| Cash Growth | 52.21% | 19.68% | 27.13% | 49.59% | -30.51% | -8.58% | Upgrade
|
| Accounts Receivable | 244.15 | 299.1 | 274.25 | 275.52 | 632.87 | 447.67 | Upgrade
|
| Other Receivables | 18.69 | 18.94 | 23.24 | 16.9 | 2.48 | 2.56 | Upgrade
|
| Receivables | 262.84 | 318.04 | 297.48 | 292.42 | 635.35 | 450.23 | Upgrade
|
| Inventory | 403.97 | 372.44 | 426.81 | 602.01 | 536.48 | 400.63 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.01 | Upgrade
|
| Other Current Assets | 80.05 | 134.18 | 62.73 | 18.39 | 38.72 | 33.04 | Upgrade
|
| Total Current Assets | 2,029 | 1,910 | 1,694 | 1,626 | 1,687 | 1,570 | Upgrade
|
| Property, Plant & Equipment | 694.22 | 681.93 | 563.6 | 561.27 | 616.39 | 611.77 | Upgrade
|
| Long-Term Investments | 132.97 | 134.16 | 160.08 | 203.22 | 156.78 | 40.56 | Upgrade
|
| Goodwill | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 | Upgrade
|
| Other Intangible Assets | 106.39 | 107.21 | 109.32 | 113.14 | 100.86 | 106.92 | Upgrade
|
| Long-Term Deferred Tax Assets | 66.35 | 66.52 | 75.26 | 90.53 | 101.49 | 99.42 | Upgrade
|
| Long-Term Deferred Charges | 183.09 | 173.03 | 138.04 | 93.77 | 60.33 | 46.85 | Upgrade
|
| Other Long-Term Assets | 8.99 | 4.47 | 15.3 | 3.05 | 71.67 | 21.81 | Upgrade
|
| Total Assets | 3,232 | 3,088 | 2,830 | 2,766 | 2,806 | 2,508 | Upgrade
|
| Accounts Payable | 94.55 | 78.82 | 88.64 | 41.18 | 45.97 | 71.23 | Upgrade
|
| Accrued Expenses | 16.59 | 38.65 | 88.06 | 89.7 | 101.94 | 99.55 | Upgrade
|
| Short-Term Debt | - | - | 21.49 | 56.31 | 103.05 | 93.56 | Upgrade
|
| Current Income Taxes Payable | 20.11 | 7.8 | 1.53 | 0.64 | 0.05 | - | Upgrade
|
| Current Unearned Revenue | 6.21 | 7.64 | 9.68 | 9.71 | 15.58 | 19.67 | Upgrade
|
| Other Current Liabilities | 140.6 | 92.61 | 14 | 8.28 | 11.63 | 12.34 | Upgrade
|
| Total Current Liabilities | 278.06 | 225.52 | 223.39 | 205.81 | 278.22 | 296.35 | Upgrade
|
| Long-Term Leases | 3.1 | 3.07 | - | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 93.94 | 88.58 | 86.46 | 81.85 | 89.35 | 93.42 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.72 | 4.78 | 4.02 | 4.52 | 4.96 | 0.47 | Upgrade
|
| Total Liabilities | 379.82 | 321.95 | 313.87 | 292.17 | 372.53 | 390.24 | Upgrade
|
| Common Stock | 1,280 | 1,280 | 1,280 | 1,280 | 1,280 | 1,280 | Upgrade
|
| Additional Paid-In Capital | 30.21 | 41.42 | 41.65 | 41.65 | 36.29 | 29.38 | Upgrade
|
| Retained Earnings | 1,703 | 1,618 | 1,369 | 1,163 | 1,134 | 960.89 | Upgrade
|
| Treasury Stock | -156.88 | -170.86 | -170.86 | -30.09 | - | -145.05 | Upgrade
|
| Comprehensive Income & Other | -1.99 | -0.55 | -2.42 | 0.36 | -0.06 | 2.23 | Upgrade
|
| Total Common Equity | 2,854 | 2,768 | 2,517 | 2,455 | 2,450 | 2,127 | Upgrade
|
| Minority Interest | -2.24 | -1.68 | -0.87 | 18.98 | -16.95 | -9.09 | Upgrade
|
| Shareholders' Equity | 2,852 | 2,766 | 2,517 | 2,474 | 2,433 | 2,118 | Upgrade
|
| Total Liabilities & Equity | 3,232 | 3,088 | 2,830 | 2,766 | 2,806 | 2,508 | Upgrade
|
| Total Debt | 3.1 | 3.07 | 21.49 | 56.31 | 103.05 | 93.56 | Upgrade
|
| Net Cash (Debt) | 1,279 | 1,082 | 885.19 | 656.85 | 373.69 | 592.48 | Upgrade
|
| Net Cash Growth | 55.54% | 22.23% | 34.76% | 75.78% | -36.93% | -16.38% | Upgrade
|
| Net Cash Per Share | 1.03 | 0.87 | 0.70 | 0.51 | 0.29 | 0.49 | Upgrade
|
| Filing Date Shares Outstanding | 1,254 | 1,235 | 1,250 | 1,275 | 1,280 | 1,280 | Upgrade
|
| Total Common Shares Outstanding | 1,254 | 1,235 | 1,250 | 1,275 | 1,280 | 1,280 | Upgrade
|
| Working Capital | 1,751 | 1,684 | 1,470 | 1,420 | 1,409 | 1,274 | Upgrade
|
| Book Value Per Share | 2.28 | 2.24 | 2.01 | 1.93 | 1.91 | 1.66 | Upgrade
|
| Tangible Book Value | 2,737 | 2,650 | 2,397 | 2,331 | 2,338 | 2,009 | Upgrade
|
| Tangible Book Value Per Share | 2.18 | 2.15 | 1.92 | 1.83 | 1.83 | 1.57 | Upgrade
|
| Buildings | - | - | 498.75 | 498.75 | 525.73 | 524.28 | Upgrade
|
| Machinery | - | - | 568.44 | 558.3 | 504.84 | 461.29 | Upgrade
|
| Construction In Progress | - | - | 61.25 | 8.19 | 54.1 | 39.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.